References
- FritschPZelgerBLivedo vasculitisHautarzt1995463215224 quiz 222–2237759251
- GoergeTWeishauptCMetzeDLivedoid vasculopathy in a pediatric patient with elevated lipoprotein(a) levels: prompt response to continuous low-molecular-weight heparinArch Dermatol2010146892792820713839
- KerkNGoergeTLivedoid vasculopathy – current aspects of diagnosis and treatment of cutaneous infarctionJ Dtsch Dermatol Ges201311540741023437985
- KerkNDrabikALugerTSchneiderSWGoergeTRivaroxaban prevents painful cutaneous infarctions in livedoid vasculopathyBr J Dermatol2013168489889923106384
- WeishauptCStrölinAKahleBAnticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trialLancet Haematol201632e72e7926853646
- CallenJPLivedoid vasculopathy: what it is and how the patient should be evaluated and treated. [comment]Arch Dermatol2006142111481148217116840
- MarzanoAVVezzoliPBertiESkin involvement in cutaneous and systemic vasculitisAutoimmun Rev201312446747622959234
- Gonzalez-SantiagoTMDavisMDUpdate of management of connective tissue diseases: livedoid vasculopathyDermatol Ther201225218319422741937
- HairstonBRDavisMDPittelkowMRAhmedILivedoid vasculopathy: further evidence for procoagulant pathogenesisArch Dermatol2006142111413141817116831
- DavisMDWysokinskiWEUlcerations caused by livedoid vasculopathy associated with a prothrombotic state: response to warfarinJ Am Acad Dermatol200858351251518280355
- GoergeTNiedermolekulare Heparin-Therapie zur Behandlung der Livedovaskulopathie [Low-molecular-weight heparin for the treatment of livedoid vasculopathy]Aktuelle Derm201036484487
- SunderkotterCde GrootKTherapie von Vaskulitiden und Vaskulopathien [Therapy of vasculitides and vasculopathies]Hautarzt20085938239318777639
- BrowningCECallenJPWarfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemiaArch Dermatol20061421757816415390
- DengAGockeCDHessJHeymanMPaltielMGaspariALivedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activatorArch Dermatol2006142111466146917116837
- KreuterAGambichlerTBreuckmannFPulsed intravenous immunoglobulin therapy in livedoid vasculitis: an open trial evaluating 9 consecutive patientsJ Am Acad Dermatol200451457457915389193
- PerzbornEStrassburgerJWilmenAIn vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939 – an oral, direct factor Xa inhibitorJ Thromb Haemost20053351452115748242
- LassenMRAgenoWBorrisLCRECORD3 InvestigatorsRivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplastyN Engl J Med2008358262776278618579812